Literature DB >> 18931498

Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease.

Ling Li1, Dongfeng Cao, Renee Desmond, Atiq Rahman, James J Lah, Allan I Levey, Edward Zamrini.   

Abstract

BACKGROUND: Conflicting results have been reported on the association of plasma total homocysteine (tHcy) and cholesterol levels in Alzheimer disease (AD). The objective of this study was to determine the relationship between cognitive performance and plasma levels of tHcy and its biological determinants folate and vitamin B(12), and lipids in clinically diagnosed AD patients.
METHODS: A cross-sectional database review was performed on two separate groups of patients (n = 191). Mini-Mental State Exam (MMSE) scores, plasma levels of tHcy, vitamin B(12), folate, cholesterol, and triglycerides were analyzed.
RESULTS: The MMSE scores were inversely correlated with age, plasma levels of tHcy and LDL cholesterol. However, only the inverse relationship between MMSE scores and LDL cholesterol levels persisted after adjustment for age, sex, and status of statin treatment. Plasma tHcy levels increased significantly with age and were inversely related to vitamin B(12) and folate levels, which modified the relationship between MMSE scores and plasma tHcy levels.
CONCLUSIONS: The plasma tHcy levels appeared to relate more to aging than to cognition. Cognitive performance was inversely associated with plasma LDL cholesterol levels in AD patients. Our findings provide further evidence that high LDL cholesterol levels may play a role in the pathogenesis of AD. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931498      PMCID: PMC2679366          DOI: 10.1159/000164271

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  52 in total

Review 1.  The prevalence of dementia: a quantitative integration of the literature.

Authors:  A F Jorm; A E Korten; A S Henderson
Journal:  Acta Psychiatr Scand       Date:  1987-11       Impact factor: 6.392

2.  Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein.

Authors:  S Bodovitz; W L Klein
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

Authors:  D L Sparks; S W Scheff; J C Hunsaker; H Liu; T Landers; D R Gross
Journal:  Exp Neurol       Date:  1994-03       Impact factor: 5.330

5.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

6.  Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging.

Authors:  Mary N Haan; Joshua W Miller; Allison E Aiello; Rachel A Whitmer; William J Jagust; Dan M Mungas; Lindsay H Allen; Ralph Green
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

7.  Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people.

Authors:  I R Bell; J S Edman; J Selhub; F D Morrow; D W Marby; H L Kayne; J O Cole
Journal:  Acta Psychiatr Scand       Date:  1992-11       Impact factor: 6.392

8.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study.

Authors:  K M Riggs; A Spiro; K Tucker; D Rush
Journal:  Am J Clin Nutr       Date:  1996-03       Impact factor: 7.045

9.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.

Authors:  J Selhub; P F Jacques; P W Wilson; D Rush; I H Rosenberg
Journal:  JAMA       Date:  1993-12-08       Impact factor: 56.272

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  10 in total

1.  Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.

Authors:  Eric M Reiman; Kewei Chen; Jessica B S Langbaum; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Richard J Caselli
Journal:  Neuroimage       Date:  2009-07-23       Impact factor: 6.556

Review 2.  The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial.

Authors:  Kun Xuan; Tianming Zhao; Guangbo Qu; Haixia Liu; Xin Chen; Yehuan Sun
Journal:  Neurol Sci       Date:  2020-01-13       Impact factor: 3.307

3.  Collaborative Management of Neurocognitive Disorders in Primary Care: Explorations of an Attempt at Culture Change.

Authors:  Lewis Mehl-Madrona; Barbara Mainguy
Journal:  Perm J       Date:  2017-01-06

4.  Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-12

5.  Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles.

Authors:  G T Lesser; M S Beeri; J Schmeidler; D P Purohit; V Haroutunian
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

6.  Role of vitamin B(12), folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population.

Authors:  Rachna Agarwal; Neelam Chhillar; Suman Kushwaha; Neeraj Kumar Singh; Chandra Bhushan Tripathi
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

7.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

8.  Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.

Authors:  Ming-Kung Wu; Yan-Ting Lu; Chi-Wei Huang; Pin-Hsuan Lin; Nai-Ching Chen; Chun-Chung Lui; Wen-Neng Chang; Chen-Chang Lee; Ya-Ting Chang; Sz-Fan Chen; Chiung-Chih Chang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.

Authors:  Federica Barocco; Marco Spallazzi; Letizia Concari; Simona Gardini; Annalisa Pelosi; Paolo Caffarra
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis.

Authors:  May A Beydoun; Hind A Beydoun; Alyssa A Gamaldo; Alison Teel; Alan B Zonderman; Youfa Wang
Journal:  BMC Public Health       Date:  2014-06-24       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.